AzTrials
AzTrials

Ultrasound Therapy; ComplicationsNCT03816709

Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound

A study testing Therapeutic Ultrasound in people with Ultrasound Therapy; Complications, run by North Dakota State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Ultrasound Therapy; Complications
What is being tested?
Therapeutic Ultrasound
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteUnited States
Study dates
5 Feb 2019to 11 May 2020
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • males and females between the ages of 18 - 35 years old
  • able to speak English
  • have less than 1 cm of adipose over the left medial gastrocnemius muscle.

Who cannot join

  • any current lower extremity injury
  • any lower extremity injuries within the last 6 months
  • open wounds
  • skin infections
  • impaired circulation
  • peripheral vascular disease
Show all 16Show fewer
  • deep vein thrombosis
  • advanced arthritis
  • poor thermal regulation
  • anesthetic areas
  • neoplasms/tumors
  • thrombophlebitis
  • closed infections
  • any allergies or sensitivities to betadine
  • any abnormalities observed in the medial gastrocnemius muscle determined by diagnostic ultrasound
  • 1.0 cm or greater adipose over the left medial gastrocnemius muscle.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • North Dakota State University

    Fargo, North Dakota, 58108-6050

Other trials in United States

About this study

Official title: Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound With 3 MHz, 1.0 W/cm2 at Three Depths up to 2.5 cm

The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be inserted at 1.0, 1.75, and 2.5 cm depths to determine the heating rates. Most modality textbook recommendations for therapeutic ultrasound are based on studies performed with the Omnisound ultrasound machine. Previous research has shown variations in power output across manufacturers, producing differences in tissue temperature increases. No information has been published regarding the heating rates of the Chattanooga Intelect Legend XT machine for ultrasound treatments. By determining the heating rates for this machine, clinicians will be better able to utilize the Chattanooga Intelect Legend XT to help reach therapeutic goals.

Read the detailed description

Individual subjects will report to the research lab. They will be instructed to wear appropriate shorts or pants that can be rolled up to expose the gastrocnemius (calf) muscle. The subject will lay prone on the treatment table with the foot and lower leg off of the treatment table in a relaxed, comfortable position. The following procedures will be completed using universal precautions:

  1. The investigator will prep the treatment area by having the subject flex the calf to determine the proper location for the ultrasound treatment in the middle of the medial gastrocnemius muscle belly at its largest girth.
  2. A carpenter's square with markings along the vertical arm at the three experimental depths (1.0, 1.75, 2.5 cm) will be used.
  3. The horizontal arm of the carpenter's square will be covered in tape. The carpenter's square is then placed just proximal to the treatment mark while the level on the horizontal arm is used to maintain a level measure.
  4. Marks will be made on the muscle belly parallel to the marks on the vertical axis at 1.0, 1.75 and 2.5 cm depths.
  5. A mark is also made on the horizontal arm tape in line with the treatment mark on the medial gastrocnemius.
  6. The Terason uSmart 3300 diagnostic ultrasound unit will be used to measure the adipose thickness over the treatment area and look for abnormalities in the treatment and thermocouple insertion areas. Aquasonic® 100 ultrasound gel will be placed on the 15L4 transducer. The transducer with gel will be placed over the mark of the treatment area. Once the transducer is in place, the screen will be frozen and the skin and adipose thickness will be measured using the caliper tool.
  7. The thermocouples will be removed from the MetriCide after sterilizing for a minimum of 12 hours prior to insertion.
  8. The distal aspect of the thermocouple will be wiped dry with sterile gauze.
  9. A mark with a sharpie will be made on each thermocouple just past the length marked on the horizontal arm of the carpenter's square. This allows the tip of each thermocouple to be directly below the treatment site. A second mark will be made at 5 cm to make sure the thermocouple does not go too deep into the tissue.
  10. The distal end of the thermocouple will be wiped clean again using a 70% isopropyl alcohol wipe up to the marks and then the thermocouple will be wrapped in sterile gauze until it is inserted.
  11. The insertion areas will be shaved to remove any body hair (if necessary) and cleaned using Betadine.
  12. Once the Betadine dries, 70% isopropyl alcohol will be wiped over the insertion area and given time to dry.
  13. The subject will be instructed to take two deep breaths, while the researcher lightly grasps the gastrocnemius to confirm muscle relaxation.
  14. During the second exhalation, the 1.16 in needle catheter will be placed into the subject's calf at the 1.0 cm depth insertion mark using the level to guide the needle in. The needle will be removed leaving the catheter in the tissue.
  15. The thermocouple will be threaded through the catheter to the appropriate depth marked on the thermocouple and the catheter will be removed.
  16. The thermocouple will be secured using medical tape to keep it from moving.
  17. This procedure will be performed 3 times, with one thermocouple placed at each respective depth: 1.0 cm, 1.75 cm, and 2.5 cm.
  18. Each thermocouple will be attached to the Iso Thermex electronic thermometer (Columbus Instruments, Columbus, OH), which will measure and record intramuscular temperatures from the tips of the thermocouples.
  19. An ultrasound treatment template will be applied at the treatment site and secured with tape to maintain consistent treatment size.
  20. This template will be twice the size of the transducer's Effective Radiating Area (ERA).
  21. A metronome will be utilized to consistently move the transducer at a rate of 4 cm/s .
  22. The ultrasound treatment will begin once the intramuscular temperature has remained the same for a minute.
  23. Each subject will receive one ultrasound treatment at the following parameters: 3 MHz frequency, 1.0 W/cm2 intensity, and 100% duty cycle using the Chattanooga Intelect® Legend XT.
  24. Termination of treatment will result when any of the following occur: i. A 15-minute treatment time is obtained. ii. A 4°C temperature increase occurs at all three depths as this has been shown as the necessary temperature change to increase tissue extensibility. iii. A 45°C temperature is reached at any depth, due to concern of tissue damage at high temperatures. iv. The subject experiences any pain or discomfort during the treatment.
  25. Following the treatment, the ultrasound gel will be wiped from the leg, the template and thermocouples will be removed, and the insertion sites will be cleaned with 70% isopropyl alcohol wipes and covered with a band aid.
  26. The subject will then be instructed on the possibility of minor soreness for the next day or two and instructed on an icing schedule to decrease discomfort.
Being tested
Therapeutic Ultrasound
Keywords
heating rates, therapeutic ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapeutic UltrasoundDevice

    Also called Ultrasound therapy

    A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes.

Study groups in NCT03816709
Study groupRoleWhat they receive
Therapeutic ultrasound treatmentOtherAll subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.
Receives: Device: Therapeutic Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heating Rate at 1 cm Depth

    A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.

    Measured: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)

  2. Heating Rate at 1.75 cm Depth

    A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.

    Measured: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 8 minutes)

  3. Heating Rate at 2.5 cm Depth

    A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.

    Measured: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which did not occur in the 15 minute treatment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2019
  2. Study start5 Feb 2019
  3. Primary completion15 Apr 2020
  4. Study completion11 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03816709
Sponsor's protocol ID
HE19132
Status last verified
May 2021
First submitted
23 Jan 2019
Last updated
27 May 2021
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Once the data has been analyzed to determine the heating rates, a manuscript including the heating rates will be submitted for publication.

Publications

  • Gange KN, Kjellerson MC, Berdan CJ. The Dynatron Solaris(R) Ultrasound Machine: Slower Heating Than Textbook Recommendations at 3 MHz, 1.0 W/cm2. J Sport Rehabil. 2018 Jan 1;27(1):22-29. doi: 10.1123/jsr.2016-0173. Epub 2018 Jan 18.

    PubMed 27992304
  • Merrick MA, Bernard KD, Devor ST, Williams MJ. Identical 3-MHz ultrasound treatments with different devices produce different intramuscular temperatures. J Orthop Sports Phys Ther. 2003 Jul;33(7):379-85. doi: 10.2519/jospt.2003.33.7.379.

    PubMed 12918863
  • Draper DO, Castel JC, Castel D. Rate of temperature increase in human muscle during 1 MHz and 3 MHz continuous ultrasound. J Orthop Sports Phys Ther. 1995 Oct;22(4):142-50. doi: 10.2519/jospt.1995.22.4.142.

    PubMed 8535471

Questions about this trial

What is this clinical trial studying?

A study testing Therapeutic Ultrasound in people with Ultrasound Therapy; Complications, run by North Dakota State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 27 May 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heating Rate at 1 cm Depth (time frame: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03816709, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in